On June 24, 2025, Orchestra BioMed held its Annual Meeting of Stockholders where shareholders voted to elect three directors and ratified Ernst & Young LLP as independent auditors for the fiscal year ending December 31, 2025. A total of 28,177,159 out of 38,312,512 shares were represented at the meeting.